Hematologic Disorder
Showing 1 - 25 of >10,000
Hematological Disorder in Patients With Angiodysplasia
Not yet recruiting
- Angiodysplasia
- Hematological Disease
- Von willebrand antigen
- (no location specified)
Sep 26, 2023
Study of Non-Neoplastic Hematologic Disorders
Recruiting
- Hematologic Disorder
- +8 more
-
Phoenix, Arizona
- +9 more
May 18, 2022
Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial
Not yet recruiting
- Chronic Graft-versus-Host-Disease
- +4 more
- (no location specified)
Jan 11, 2023
Examining the Experiences of Children With Blood Disorders
Recruiting
- Blood Disease
- +4 more
-
Dallas, TexasThe University of Texas Southwestern Medical Center
Jan 16, 2023
(Proteomic and Genomic Analysis of Biospecimens)
Enrolling by invitation
- Oncology
- +8 more
- Observational Study Only. NO Intervention.
-
New Orleans, LouisianaAUD
Jun 2, 2023
Non-Hodgkin's Lymphoma (Disorder), Acute Lymphoid Leukemia, Disease (Disorder) Trial in Louisville, Houston (1A46 Injection)
Recruiting
- Non-Hodgkin's Lymphoma (Disorder)
- Acute Lymphoid Leukemia, Disease (Disorder)
- 1A46 Injection
-
Louisville, Kentucky
- +1 more
Aug 1, 2022
Probability of Optimal Target Attainment of Amikacin in Febrile
Recruiting
- Febrile Neutropenia (FN)
- Data collection: Amikacin concentration
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Internal Medicine
Jan 18, 2023
Liver Diseases, Blood Disorder, Digestive System Disease Trial in Hershey (Aerobic Exercise)
Completed
- Liver Diseases
- +2 more
- Aerobic Exercise
-
Hershey, PennsylvaniaPenn State Hershey Medical Center
Jan 31, 2023
Hematological Disorder Trial in Chapel Hill (Focus Group Discussions and Semi-structured Interviews, Training community lay
Not yet recruiting
- Hematological Disorder
- Focus Group Discussions and Semi-structured Interviews
- Training community lay navigators
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center, UNC
Apr 12, 2023
Eosinophilia, Hypereosinophilic Syndrome, Leukocyte Disorder Trial run by the NIAID (prednisone)
Completed
- Eosinophilia
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 26, 2022
Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,
Recruiting
- Acute Myeloid Leukemia in Remission
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Hematologic Malignancy, Anxiety, Depression Trial in Addis Ababa, Gondar (Cognitive-behavioural intervention)
Recruiting
- Hematologic Malignancy
- +3 more
- Cognitive-behavioural intervention
-
Addis Ababa, Ethiopia
- +1 more
Jul 19, 2022
Using Genomics in Inherited Bone Marrow Failure (IBMDx Study)
Recruiting
- Inherited BMF Syndrome
- +2 more
- whole genome and transcriptome sequencing
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Mar 28, 2022
Advanced Cancers, Hematologic Disorder, Solid Tumors Trial in Houston (drug, behavioral, device, other)
Completed
- Advanced Cancers
- +2 more
- Dexamethasone
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 31, 2021
Infections, Heart Failure, COPD Exacerbation Trial in Boston (Health Information Exchange (HIE) platform)
Not yet recruiting
- Infections
- +15 more
- Health Information Exchange (HIE) platform
-
Boston, MassachusettsBrigham & Women's Hospital
Jun 29, 2022
Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder Trial in Rochester (radiation, drug, procedure)
Recruiting
- Acute Leukemia
- +9 more
- Total Body Irradiation 1200 cGy
- +7 more
-
Rochester, New YorkWilmot Cancer Institute
Jun 20, 2022
Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in United States (drug, other, biological)
Recruiting
- Hematologic and Lymphocytic Disorder
- Hematopoietic and Lymphoid Cell Neoplasm
- Placebo Administration
- +3 more
-
Duarte, California
- +3 more
Dec 14, 2022
Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,
Active, not recruiting
- Acute Leukemia
- +4 more
- Fludarabine
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Hematologic Malignancy, Myeloproliferative Disorder Trial in New York (Isavuconazole)
Completed
- Hematologic Malignancy
- Myeloproliferative Disorder
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 15, 2021
Cancer, Hematologic Disorder, Rheumatologic Disorder Trial in Lexington, Louisville (Ovarian Cryopreservation)
Completed
- Cancer
- +3 more
- Ovarian Cryopreservation
-
Lexington, Kentucky
- +1 more
Dec 6, 2020
Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical
Recruiting
- Hemoglobinopathy (Disorder)
- +2 more
- Haploidentical Hematopoietic Cell Transplantation
-
Saint Petersburg, FloridaJohns Hopkins All Children's Hospital
Sep 13, 2022
Guardian, Hematologic and Lymphocytic Disorder, Malignant Tumor Trial in Buffalo (Educational Activity, Patient Monitoring,
Completed
- Guardian
- +3 more
- Educational Activity
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 13, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 1, 2022
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States
Recruiting
- Acute Myelogenous Leukemia (AML)
- +5 more
- Conditioning Chemotherapy
- Cord blood graft
-
Basking Ridge, New Jersey
- +6 more
May 22, 2023